Trigeminal Nerve Stimulation Treatment for Children Aged 8-12 with ADHD Caused by Prenatal Alcohol Exposure
Led by University of California, Los Angeles · Updated on 2026-10-27
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating trigeminal nerve stimulation TNS as a treatment for children aged 8 to 12 years with attention deficit hyperactivity disorder ADHD linked to prenatal alcohol exposure PAE. TNS, which has been cleared by the FDA for pediatric ADHD, uses a mild electrical current applied overnight to the forehead to stimulate the brain. This study aims to test the safety, tolerability, and preliminary effectiveness of TNS specifically for ADHD caused by PAE, as this has not been studied before. Additionally, the trial investigates brain activity changes using magnetic resonance imaging MRI.
Children will receive TNS treatment at home, administered by a parent for 8 hours each night during sleep, over a period of four weeks. The small device used is easy to operate and attaches to the forehead with electrodes. Participants will attend three clinic visits for eligibility assessment, pre-treatment evaluation including an MRI scan, and post-treatment evaluation with a second MRI. After the treatment phase, a follow-up phone call will check on the persistence of any improvements.
During the study, children will be assessed using ADHD rating scales and clinical global impression scores before and after the TNS treatment. MRI scans will help explore the brain mechanisms affected by TNS. Families will participate in a telephone follow-up four weeks post-treatment to evaluate lasting effects. The entire study involves a commitment of about four weeks for treatment with several clinic visits and one follow-up call, focusing on safety, tolerance, and brain imaging outcomes.
CONDITIONS
Brief Title
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Research Team
J
Jennifer M Korthas, BS
J
Joseph O'Neill, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
TNS (PAE‑associated ADHD)
FDA‑cleared TNS (standard pediatric ADHD)
What it is
A small‑device delivering mild overnight trigeminal nerve stimulation at home, applied nightly for 4 weeks in children with ADHD related to prenatal alcohol exposure.
An FDA‑cleared external TNS device for pediatric ADHD delivered at home overnight per approved label.
Role in trial
This is the investigational neuromodulation intervention applied in the study population.
Not used in the trial—shown here for comparison only.
Primary use
Exploratory treatment of ADHD symptoms in children with prenatal alcohol exposure.
Nonpharmacological device‑based treatment for ADHD in children aged 7–12 without PAE.
How it is given or performed
Applied nightly at bedtime by a parent at home via a cell‑phone‑sized device and electrodes taped to the forehead for about 4 weeks.
Delivered nightly by parents using a home‑based external TNS device as per approved device instructions.
Evidence status
Feasibility in PAE‑associated ADHD being evaluated; no efficacy results yet published.
Initial randomized controlled trial showed symptom reduction (~31 % vs 18 %) in active versus sham TNS in pediatric ADHD.
Important limitations
Open‑label design, small sample, no control group—all limit ability to determine efficacy.
Initial trials lacked rigorous placebo control; later larger trial failed to find symptom benefit over sham in 150 youth.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 8Years - 12Years
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosed with fetal alcohol syndrome, partial fetal alcohol syndrome, or alcohol-related neurodevelopmental disorder based on modified criteria
Prenatal alcohol exposure of more than 6 drinks per week for at least 2 weeks or 3 or more drinks on at least 2 occasions during pregnancy
Diagnosed with ADHD according to DSM-5, including symptoms of inattention, hyperactivity, impulsivity, or executive function problems
Parent and child able to complete testing in English
Child able to cooperate during MRI procedures
Full-scale intelligence quotient greater than 70
Child able to comply with study procedures
Age between 8 and 12 years
You will not qualify if you...
Exposure to other toxins during pregnancy that have a stronger effect than alcohol
Known genetic syndromes linked to ADHD-like symptoms such as fragile X or tuberous sclerosis
Serious medical or neurological illnesses affecting brain function, including seizures or head trauma
Premature birth before 34 weeks gestation
Presence of ferromagnetic metal, claustrophobia, or contraindications to MRI or TNS, including insulin pumps or body-worn devices
Diagnosis of autism spectrum disorder, psychotic disorder, or major mood disorder
Active suicidal thoughts or history of suicide attempts as indicated by clinical assessments
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
One visit lasting 4 to 5 hours
Pre-Treatment Evaluation
Duration - 1 day
Participants undergo baseline assessments including MRI scans and ADHD symptom ratings before starting treatment.
One visit lasting 2 to 3 hours
Treatment
Duration - 4 weeks
Participants receive nightly trigeminal nerve stimulation at home, administered by a parent during sleep for 8 hours each night over 4 weeks.
Daily use at home, with no required clinic visits
Post-Treatment Evaluation
Duration - 1 day
Participants return for follow-up assessments including MRI scans and ADHD symptom ratings after treatment completion.
One visit lasting 2 to 3 hours
Follow-up
Duration - 4 weeks after treatment ends
Families participate in a telephone follow-up to check if any improvements from treatment have lasted.
One telephone call
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Study of Flexible Dosing of Dyanavel XR for Treating Fatigue in Adults with ADHD in a 10-Week Randomized, Double-Blind Trial
Study of Brain Stimulation Therapy for Children Aged 12 to 17 With ADHD to Improve Inhibitory Control
Study of Adults with Attention Deficit Hyperactivity Disorder and Addictions
Assessing Neuropsychological Profiles and Treatments with Methylphenidate
Brain Imaging and Development Study for Infants and Children up to 75 Years
Optimizing the CARRII Online Intervention to Reduce Alcohol-Exposed Pregnancy Risk in Native Women Ages 18 to 44
Study of Social Cognition in Children and Teens With Neurodevelopmental Disorders Using a Multidimensional Assessment
Study of Transcranial Direct Current Stimulation and Cognitive Training for Children and Teens with Fetal Alcohol Spectrum Disorders
Evaluating Transcranial Direct Current Stimulation tDCS with Cognitive Training for Children Ages 7 to 14 with ADHD
Observational Study of Brain Development, Impulsivity, and Compulsivity in Ages 6 to 80
Development and Use of a Diagnosis and Treatment System for Childrens Brain Disorders
Using Knowledge Graphs and Large Models
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Trigeminal nerve stimulation (TNS) for children with attention deficit/hyperactivity disorder and fetal alcohol spectrum disorder: Feasibility study protocol.
Trigeminal Nerve Stimulation (TNS) for Children with Attention Deficit/Hyperactivity Disorder and Fetal Alcohol Spectrum Disorder: Feasibility Study Protocol.